India, July 28 -- The Government of India has issued a release:
Presently, prices of drugs are regulated as per the provisions of the Drugs (Prices Control) Order 2013 (DPCO, 2013) based on the National Pharmaceuticals Pricing Policy, 2012. As per extant provisions of DPCO, 2013, the National Pharmaceutical Pricing Authority (NPPA) fix the ceiling prices of the drugs included in the Schedule-I of DPCO, 2013 which is based on the National List of Essential Medicines and the retail price of new drugs as defined in para 2(1)(u) of DPCO, 2013. Ceiling prices of scheduled drugs are revised every year on the basis of Wholesale Price Index (WPI). Further, in the case of non-scheduled formulations, manufacturers are required to not increase the maximum retail price (MRP) of such formulation by more than 10% of the MRP of that formulation during preceding 12 months. In addition, NPPA also fixes the prices of drugs under Para 19 of the DPCO, 2013 in case of extra-ordinary circumstances and in public interest. Instances of overcharging are dealt with as per the provisions of DPCO, 2013. Details of prices fixed or revised by NPPA are available on NPPA's website (www.nppa.gov.in).
NPPA monitors availability of drugs in the country and takes remedial measures whenever an issue of non-availability of any medicine is brought to its notice through various sources including State Drugs Controllers (SDCs), Pharma Jan Samadhan Portal, NPPA helpline and public grievance portals and individuals. In addition, Government has taken other measures to improve the access of essential medicines at affordable rates to the common man which include the following:
This information was given by Minister of State for Chemicals and Fertilizers Smt. Anupriya Patel, in a written reply in the Rajya Sabha today.
Disclaimer: Curated by HT Syndication.
